Market Tracker

08/18 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

16.20
Delayed Data
As of Aug 18
 -0.20 / -1.22%
Today’s Change
3.20
Today|||52-Week Range
19.60
+310.13%
Year-to-Date

Today’s Trading

Previous close16.40
Today’s open16.35
Day’s range16.15 - 16.60
Volume1,419,090
Average volume (3 months)2,333,548
Market cap$967.9M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+27.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book7.01

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-0.41-2.10%
DERMDermira Inc-0.49-2.09%
XNCRXencor Inc-0.41-2.01%
ACORAcorda Therapeutics ...+0.10+0.46%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts